Avextra
Avextra is a cannabis-based medicines developer founded in 2019.
1
Funding Rounds
$22.0m
Money raised
Overview
Avextra is a cannabis-based medicines developer founded in 2019.
- Website:
- Headquarters: Frankfurt
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Avextra has raised a total of $22m in funding over 1 rounds.
Key Insights:
- Avextra February 2024 Series B Funding Round: $22m
Avextra February 2024 Series B Funding Round
$22m